Quest Diagnostics profit slips 11% on slow demand for non-COVID tests By Reuters – News Couple

Quest Diagnostics profit slips 11% on slow demand for non-COVID tests By Reuters

© Reuters. FILE PHOTO: A test tube labeled “COVID-19 test positive” is seen in this illustrative photo taken, March 10, 2021. REUTERS/Dado Rovich/Illustration

(Reuters) – U.S. lab Quest Diagnostics (NYSE:INC) on Thursday reported an 11% drop in third-quarter profit as the spread of a highly contagious variable delta impacted demand for companies unaffected by the coronavirus.

Net income attributable to the company fell to $505 million, or $4.02 per share, in the quarter ended September 30, from $568 million, or $4.14 per share, a year earlier.

Disclaimer: Fusion Media I would like to remind you that the data on this website is not necessarily current or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges but by market makers, and therefore prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not appropriate for trading purposes. Therefore Fusion Media assumes no responsibility for any business losses you may incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media shall have no liability for loss or damage as a result of reliance on the information including statements, quotes, charts and buy/sell signals included on this website. Please be fully aware of the risks and costs associated with trading in the financial markets, it is one of the riskiest forms of investment.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button